Oncoinvent ASA(DE:7BG)
€6.14+0.30 (+5.14%)
DE:7BG
Oncoinvent ASA earnings date
€6.14
At close:+0.30 (+5.14%)
Oncoinvent ASA (7BG) Q4 2021 Earnings Report
2 Followers
DE:7BG Q4 2021 EPS Results
- Actual EPS
- -EUR 54.22
- Consensus EPS
- -EUR 5.38
- Beat/Miss
- Missed by -EUR 48.83
- One Year Ago EPS
- -EUR 55.61
DE:7BG Q4 2021 Revenue Results
- Actual Revenue
- EUR 73.18K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 73.18K
- YoY Revenue Growth
- +28.79%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/16/2022
- Time
- Before Open
- Conference Call
- Wednesday, February 16, 2022
DE:7BG Upcoming Earnings
Oncoinvent ASA's next earnings date is estimated for November 17, 2026, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:7BG Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 17, 2026 | 2026 (Q3) | ―- | -8.39 | ― | ― |
| Aug 27, 2026 | 2026 (Q2) | ―-1.44 | -8.39 | 82.88% (+6.95) | |
| May 27, 2026 | 2026 (Q1) | ―- | ― | ― | |
| Feb 26, 2026 | 2025 (Q4) | ―-6.45 | -6.6 | 2.36% (+0.16) | |
| Nov 19, 2025 | 2025 (Q3) | ―- | -0.06 | ― | |
| Aug 27, 2025 | 2025 (Q2) | ―-8.39 | -8.42 | 0.35% (+0.03) | |
| May 21, 2025 | 2025 (Q1) | ―- | -0.09 | ― | |
| Feb 26, 2025 | 2024 (Q4) | -6.60-6.60 | -12.12 | 45.50% (+5.51) | |
| Nov 13, 2024 | 2024 (Q3) | -8.12-3.82 | -6.06 | 37.00% (+2.24) | |
| Aug 21, 2024 | 2024 (Q2) | -7.57-8.42 | -90.88 | 90.73% (+82.46) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
